nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—UGT1A8—mouth—Crohn's disease	0.024	0.218	CbGeAlD
Morphine—UGT2B15—gall bladder—Crohn's disease	0.0227	0.205	CbGeAlD
Morphine—Naloxone—TLR4—Crohn's disease	0.0157	0.889	CrCbGaD
Morphine—UGT1A8—digestive system—Crohn's disease	0.0106	0.0963	CbGeAlD
Morphine—OPRL1—lymphoid tissue—Crohn's disease	0.0105	0.095	CbGeAlD
Morphine—UGT1A3—digestive system—Crohn's disease	0.00948	0.0859	CbGeAlD
Morphine—UGT2B15—digestive system—Crohn's disease	0.00892	0.0807	CbGeAlD
Morphine—OPRL1—lymph node—Crohn's disease	0.00592	0.0536	CbGeAlD
Morphine—UGT2B7—digestive system—Crohn's disease	0.00545	0.0493	CbGeAlD
Morphine—Withdrawal symptom—Prednisone—Crohn's disease	0.00538	0.00941	CcSEcCtD
Morphine—Hyperaesthesia—Mesalazine—Crohn's disease	0.00532	0.0093	CcSEcCtD
Morphine—Intracranial pressure increased—Prednisone—Crohn's disease	0.00528	0.00924	CcSEcCtD
Morphine—Withdrawal syndrome—Prednisone—Crohn's disease	0.00528	0.00924	CcSEcCtD
Morphine—Rhinorrhoea—Mesalazine—Crohn's disease	0.00515	0.00901	CcSEcCtD
Morphine—Breast disorder—Mercaptopurine—Crohn's disease	0.00504	0.00882	CcSEcCtD
Morphine—Delirium—Mesalazine—Crohn's disease	0.00485	0.00848	CcSEcCtD
Morphine—Tenderness—Mesalazine—Crohn's disease	0.00478	0.00836	CcSEcCtD
Morphine—Amenorrhoea—Mesalazine—Crohn's disease	0.00475	0.00831	CcSEcCtD
Morphine—Vasodilation—Mesalazine—Crohn's disease	0.00475	0.00831	CcSEcCtD
Morphine—Vasodilation procedure—Mesalazine—Crohn's disease	0.00475	0.00831	CcSEcCtD
Morphine—UGT1A1—digestive system—Crohn's disease	0.00463	0.0419	CbGeAlD
Morphine—Drug withdrawal syndrome—Prednisone—Crohn's disease	0.0045	0.00787	CcSEcCtD
Morphine—Stomatitis—Mercaptopurine—Crohn's disease	0.00419	0.00733	CcSEcCtD
Morphine—Abnormal dreams—Mesalazine—Crohn's disease	0.00412	0.00721	CcSEcCtD
Morphine—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00407	0.00711	CcSEcCtD
Morphine—Menstruation irregular—Prednisone—Crohn's disease	0.00399	0.00697	CcSEcCtD
Morphine—Coma—Mesalazine—Crohn's disease	0.00381	0.00667	CcSEcCtD
Morphine—Bladder pain—Mesalazine—Crohn's disease	0.00377	0.0066	CcSEcCtD
Morphine—Hypertonia—Mesalazine—Crohn's disease	0.00366	0.0064	CcSEcCtD
Morphine—Gastroenteritis—Mesalazine—Crohn's disease	0.00342	0.00598	CcSEcCtD
Morphine—Disorientation—Mesalazine—Crohn's disease	0.00339	0.00592	CcSEcCtD
Morphine—Malnutrition—Mercaptopurine—Crohn's disease	0.00336	0.00588	CcSEcCtD
Morphine—Eye pain—Mesalazine—Crohn's disease	0.00335	0.00587	CcSEcCtD
Morphine—Libido decreased—Mesalazine—Crohn's disease	0.00327	0.00571	CcSEcCtD
Morphine—Atrial fibrillation—Mesalazine—Crohn's disease	0.0032	0.00559	CcSEcCtD
Morphine—Thirst—Mesalazine—Crohn's disease	0.00318	0.00557	CcSEcCtD
Morphine—Renal impairment—Mesalazine—Crohn's disease	0.00318	0.00557	CcSEcCtD
Morphine—Dermatitis bullous—Mesalazine—Crohn's disease	0.00317	0.00554	CcSEcCtD
Morphine—Anaemia—Mercaptopurine—Crohn's disease	0.00311	0.00543	CcSEcCtD
Morphine—Lethargy—Mesalazine—Crohn's disease	0.00309	0.00541	CcSEcCtD
Morphine—Osteoarthritis—Mesalazine—Crohn's disease	0.00303	0.0053	CcSEcCtD
Morphine—Leukopenia—Mercaptopurine—Crohn's disease	0.00301	0.00526	CcSEcCtD
Morphine—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.003	0.00526	CcSEcCtD
Morphine—Affect lability—Mesalazine—Crohn's disease	0.00298	0.00521	CcSEcCtD
Morphine—Mood swings—Mesalazine—Crohn's disease	0.00287	0.00502	CcSEcCtD
Morphine—Arthralgia—Mercaptopurine—Crohn's disease	0.00286	0.005	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00284	0.00497	CcSEcCtD
Morphine—Liver function test abnormal—Mesalazine—Crohn's disease	0.0028	0.00489	CcSEcCtD
Morphine—Dry skin—Mesalazine—Crohn's disease	0.00278	0.00486	CcSEcCtD
Morphine—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00277	0.00484	CcSEcCtD
Morphine—Abdominal pain upper—Mesalazine—Crohn's disease	0.00277	0.00484	CcSEcCtD
Morphine—Oedema—Mercaptopurine—Crohn's disease	0.00274	0.0048	CcSEcCtD
Morphine—Breast disorder—Mesalazine—Crohn's disease	0.00274	0.00479	CcSEcCtD
Morphine—Cramp muscle—Mesalazine—Crohn's disease	0.00273	0.00477	CcSEcCtD
Morphine—Nasopharyngitis—Mesalazine—Crohn's disease	0.00271	0.00474	CcSEcCtD
Morphine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00269	0.0047	CcSEcCtD
Morphine—Skin disorder—Mercaptopurine—Crohn's disease	0.00266	0.00466	CcSEcCtD
Morphine—Abdominal distension—Mesalazine—Crohn's disease	0.00264	0.00461	CcSEcCtD
Morphine—Influenza—Mesalazine—Crohn's disease	0.00262	0.00458	CcSEcCtD
Morphine—Dysphagia—Mesalazine—Crohn's disease	0.00262	0.00458	CcSEcCtD
Morphine—Anorexia—Mercaptopurine—Crohn's disease	0.00261	0.00457	CcSEcCtD
Morphine—Eosinophilia—Mesalazine—Crohn's disease	0.00259	0.00453	CcSEcCtD
Morphine—Bronchospasm—Mesalazine—Crohn's disease	0.00257	0.0045	CcSEcCtD
Morphine—Delirium—Prednisone—Crohn's disease	0.00257	0.00449	CcSEcCtD
Morphine—Amenorrhoea—Prednisone—Crohn's disease	0.00251	0.00439	CcSEcCtD
Morphine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.0025	0.00437	CcSEcCtD
Morphine—Dysuria—Mesalazine—Crohn's disease	0.00245	0.00428	CcSEcCtD
Morphine—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00242	0.00424	CcSEcCtD
Morphine—Decreased appetite—Mercaptopurine—Crohn's disease	0.00238	0.00417	CcSEcCtD
Morphine—Weight decreased—Mesalazine—Crohn's disease	0.00237	0.00414	CcSEcCtD
Morphine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00237	0.00414	CcSEcCtD
Morphine—Ulcer—Prednisone—Crohn's disease	0.00233	0.00408	CcSEcCtD
Morphine—Renal failure—Mesalazine—Crohn's disease	0.00229	0.00401	CcSEcCtD
Morphine—Stomatitis—Mesalazine—Crohn's disease	0.00228	0.00398	CcSEcCtD
Morphine—Urinary tract infection—Mesalazine—Crohn's disease	0.00227	0.00397	CcSEcCtD
Morphine—Conjunctivitis—Mesalazine—Crohn's disease	0.00227	0.00397	CcSEcCtD
Morphine—Sweating—Mesalazine—Crohn's disease	0.00224	0.00391	CcSEcCtD
Morphine—Hiccups—Prednisone—Crohn's disease	0.00221	0.00386	CcSEcCtD
Morphine—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00221	0.00386	CcSEcCtD
Morphine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00217	0.00379	CcSEcCtD
Morphine—Rhinitis—Mesalazine—Crohn's disease	0.0021	0.00367	CcSEcCtD
Morphine—Hepatitis—Mesalazine—Crohn's disease	0.0021	0.00366	CcSEcCtD
Morphine—Mediastinal disorder—Azathioprine—Crohn's disease	0.00207	0.00363	CcSEcCtD
Morphine—Urinary tract disorder—Mesalazine—Crohn's disease	0.00207	0.00362	CcSEcCtD
Morphine—Oedema peripheral—Mesalazine—Crohn's disease	0.00206	0.00361	CcSEcCtD
Morphine—Chills—Azathioprine—Crohn's disease	0.00206	0.00361	CcSEcCtD
Morphine—Connective tissue disorder—Mesalazine—Crohn's disease	0.00206	0.0036	CcSEcCtD
Morphine—Urethral disorder—Mesalazine—Crohn's disease	0.00205	0.00359	CcSEcCtD
Morphine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00202	0.00353	CcSEcCtD
Morphine—Pulmonary oedema—Prednisone—Crohn's disease	0.00196	0.00344	CcSEcCtD
Morphine—Eye disorder—Mesalazine—Crohn's disease	0.00196	0.00342	CcSEcCtD
Morphine—Naloxone—ALB—Crohn's disease	0.00196	0.111	CrCbGaD
Morphine—Hyperkinesia—Prednisone—Crohn's disease	0.00193	0.00337	CcSEcCtD
Morphine—Sepsis—Prednisone—Crohn's disease	0.00192	0.00335	CcSEcCtD
Morphine—Angiopathy—Mesalazine—Crohn's disease	0.0019	0.00332	CcSEcCtD
Morphine—Euphoric mood—Prednisone—Crohn's disease	0.0019	0.00332	CcSEcCtD
Morphine—Mediastinal disorder—Mesalazine—Crohn's disease	0.00189	0.0033	CcSEcCtD
Morphine—Chills—Mesalazine—Crohn's disease	0.00188	0.00329	CcSEcCtD
Morphine—Diarrhoea—Mercaptopurine—Crohn's disease	0.00188	0.00328	CcSEcCtD
Morphine—Ill-defined disorder—Azathioprine—Crohn's disease	0.00186	0.00325	CcSEcCtD
Morphine—Anaemia—Azathioprine—Crohn's disease	0.00185	0.00324	CcSEcCtD
Morphine—Mental disorder—Mesalazine—Crohn's disease	0.00184	0.00321	CcSEcCtD
Morphine—Erythema—Mesalazine—Crohn's disease	0.00182	0.00319	CcSEcCtD
Morphine—Malaise—Azathioprine—Crohn's disease	0.00181	0.00316	CcSEcCtD
Morphine—Flatulence—Mesalazine—Crohn's disease	0.0018	0.00314	CcSEcCtD
Morphine—Leukopenia—Azathioprine—Crohn's disease	0.00179	0.00313	CcSEcCtD
Morphine—Tension—Mesalazine—Crohn's disease	0.00179	0.00313	CcSEcCtD
Morphine—Dysgeusia—Mesalazine—Crohn's disease	0.00179	0.00312	CcSEcCtD
Morphine—Nervousness—Mesalazine—Crohn's disease	0.00177	0.0031	CcSEcCtD
Morphine—Back pain—Mesalazine—Crohn's disease	0.00176	0.00309	CcSEcCtD
Morphine—Muscle spasms—Mesalazine—Crohn's disease	0.00175	0.00307	CcSEcCtD
Morphine—Vomiting—Mercaptopurine—Crohn's disease	0.00174	0.00305	CcSEcCtD
Morphine—Injury—Prednisone—Crohn's disease	0.00174	0.00305	CcSEcCtD
Morphine—Rash—Mercaptopurine—Crohn's disease	0.00173	0.00302	CcSEcCtD
Morphine—Dermatitis—Mercaptopurine—Crohn's disease	0.00173	0.00302	CcSEcCtD
Morphine—Vision blurred—Mesalazine—Crohn's disease	0.00172	0.00301	CcSEcCtD
Morphine—Tremor—Mesalazine—Crohn's disease	0.00171	0.00299	CcSEcCtD
Morphine—Amnesia—Prednisone—Crohn's disease	0.00171	0.00298	CcSEcCtD
Morphine—Arthralgia—Azathioprine—Crohn's disease	0.0017	0.00298	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00169	0.00296	CcSEcCtD
Morphine—Ill-defined disorder—Mesalazine—Crohn's disease	0.00169	0.00296	CcSEcCtD
Morphine—Anaemia—Mesalazine—Crohn's disease	0.00169	0.00295	CcSEcCtD
Morphine—Discomfort—Azathioprine—Crohn's disease	0.00168	0.00295	CcSEcCtD
Morphine—Malaise—Mesalazine—Crohn's disease	0.00164	0.00288	CcSEcCtD
Morphine—Vertigo—Mesalazine—Crohn's disease	0.00164	0.00287	CcSEcCtD
Morphine—Syncope—Mesalazine—Crohn's disease	0.00164	0.00286	CcSEcCtD
Morphine—Lethargy—Prednisone—Crohn's disease	0.00164	0.00286	CcSEcCtD
Morphine—Leukopenia—Mesalazine—Crohn's disease	0.00163	0.00286	CcSEcCtD
Morphine—Nausea—Mercaptopurine—Crohn's disease	0.00163	0.00285	CcSEcCtD
Morphine—Infection—Azathioprine—Crohn's disease	0.00162	0.00284	CcSEcCtD
Morphine—Palpitations—Mesalazine—Crohn's disease	0.00161	0.00282	CcSEcCtD
Morphine—Loss of consciousness—Mesalazine—Crohn's disease	0.0016	0.0028	CcSEcCtD
Morphine—Osteoarthritis—Prednisone—Crohn's disease	0.0016	0.0028	CcSEcCtD
Morphine—Thrombocytopenia—Azathioprine—Crohn's disease	0.0016	0.0028	CcSEcCtD
Morphine—Cough—Mesalazine—Crohn's disease	0.00159	0.00278	CcSEcCtD
Morphine—Skin disorder—Azathioprine—Crohn's disease	0.00159	0.00278	CcSEcCtD
Morphine—Affect lability—Prednisone—Crohn's disease	0.00158	0.00276	CcSEcCtD
Morphine—Hypertension—Mesalazine—Crohn's disease	0.00157	0.00275	CcSEcCtD
Morphine—Psychotic disorder—Prednisone—Crohn's disease	0.00156	0.00274	CcSEcCtD
Morphine—Chest pain—Mesalazine—Crohn's disease	0.00155	0.00272	CcSEcCtD
Morphine—Arthralgia—Mesalazine—Crohn's disease	0.00155	0.00272	CcSEcCtD
Morphine—Anxiety—Mesalazine—Crohn's disease	0.00155	0.00271	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00154	0.0027	CcSEcCtD
Morphine—Discomfort—Mesalazine—Crohn's disease	0.00153	0.00268	CcSEcCtD
Morphine—Hypotension—Azathioprine—Crohn's disease	0.00153	0.00267	CcSEcCtD
Morphine—Cardiac arrest—Prednisone—Crohn's disease	0.00152	0.00267	CcSEcCtD
Morphine—Dry mouth—Mesalazine—Crohn's disease	0.00152	0.00266	CcSEcCtD
Morphine—Mood swings—Prednisone—Crohn's disease	0.00152	0.00266	CcSEcCtD
Morphine—Confusional state—Mesalazine—Crohn's disease	0.0015	0.00263	CcSEcCtD
Morphine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00149	0.0026	CcSEcCtD
Morphine—Anaphylactic shock—Mesalazine—Crohn's disease	0.00149	0.0026	CcSEcCtD
Morphine—Oedema—Mesalazine—Crohn's disease	0.00149	0.0026	CcSEcCtD
Morphine—CYP3A4—digestive system—Crohn's disease	0.00148	0.0134	CbGeAlD
Morphine—Infection—Mesalazine—Crohn's disease	0.00148	0.00259	CcSEcCtD
Morphine—Dry skin—Prednisone—Crohn's disease	0.00147	0.00257	CcSEcCtD
Morphine—Shock—Mesalazine—Crohn's disease	0.00146	0.00256	CcSEcCtD
Morphine—CYP2D6—digestive system—Crohn's disease	0.00146	0.0132	CbGeAlD
Morphine—Nervous system disorder—Mesalazine—Crohn's disease	0.00146	0.00255	CcSEcCtD
Morphine—Hypokalaemia—Prednisone—Crohn's disease	0.00146	0.00255	CcSEcCtD
Morphine—Thrombocytopenia—Mesalazine—Crohn's disease	0.00146	0.00255	CcSEcCtD
Morphine—Tachycardia—Mesalazine—Crohn's disease	0.00145	0.00254	CcSEcCtD
Morphine—Skin disorder—Mesalazine—Crohn's disease	0.00145	0.00253	CcSEcCtD
Morphine—Hyperhidrosis—Mesalazine—Crohn's disease	0.00144	0.00252	CcSEcCtD
Morphine—Anorexia—Mesalazine—Crohn's disease	0.00142	0.00248	CcSEcCtD
Morphine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00141	0.00247	CcSEcCtD
Morphine—Abdominal distension—Prednisone—Crohn's disease	0.00139	0.00244	CcSEcCtD
Morphine—Hypotension—Mesalazine—Crohn's disease	0.00139	0.00243	CcSEcCtD
Morphine—ABCB1—epithelium—Crohn's disease	0.00138	0.0125	CbGeAlD
Morphine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00136	0.00237	CcSEcCtD
Morphine—Sweating increased—Prednisone—Crohn's disease	0.00135	0.00236	CcSEcCtD
Morphine—Feeling abnormal—Azathioprine—Crohn's disease	0.00135	0.00236	CcSEcCtD
Morphine—Insomnia—Mesalazine—Crohn's disease	0.00135	0.00235	CcSEcCtD
Morphine—Paraesthesia—Mesalazine—Crohn's disease	0.00134	0.00234	CcSEcCtD
Morphine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00134	0.00234	CcSEcCtD
Morphine—Dyspnoea—Mesalazine—Crohn's disease	0.00133	0.00232	CcSEcCtD
Morphine—Somnolence—Mesalazine—Crohn's disease	0.00132	0.00231	CcSEcCtD
Morphine—Dyspepsia—Mesalazine—Crohn's disease	0.00131	0.00229	CcSEcCtD
Morphine—Decreased appetite—Mesalazine—Crohn's disease	0.00129	0.00226	CcSEcCtD
Morphine—Body temperature increased—Azathioprine—Crohn's disease	0.00129	0.00226	CcSEcCtD
Morphine—Abdominal pain—Azathioprine—Crohn's disease	0.00129	0.00226	CcSEcCtD
Morphine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00129	0.00225	CcSEcCtD
Morphine—Fatigue—Mesalazine—Crohn's disease	0.00128	0.00224	CcSEcCtD
Morphine—Erectile dysfunction—Prednisone—Crohn's disease	0.00128	0.00223	CcSEcCtD
Morphine—Pain—Mesalazine—Crohn's disease	0.00127	0.00223	CcSEcCtD
Morphine—Constipation—Mesalazine—Crohn's disease	0.00127	0.00223	CcSEcCtD
Morphine—Weight decreased—Prednisone—Crohn's disease	0.00125	0.00219	CcSEcCtD
Morphine—Hyperglycaemia—Prednisone—Crohn's disease	0.00125	0.00219	CcSEcCtD
Morphine—Feeling abnormal—Mesalazine—Crohn's disease	0.00123	0.00215	CcSEcCtD
Morphine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00122	0.00213	CcSEcCtD
Morphine—Hypersensitivity—Azathioprine—Crohn's disease	0.0012	0.00211	CcSEcCtD
Morphine—ABCB1—mammalian vulva—Crohn's disease	0.0012	0.0108	CbGeAlD
Morphine—Urticaria—Mesalazine—Crohn's disease	0.00118	0.00207	CcSEcCtD
Morphine—Body temperature increased—Mesalazine—Crohn's disease	0.00118	0.00206	CcSEcCtD
Morphine—Abdominal pain—Mesalazine—Crohn's disease	0.00118	0.00206	CcSEcCtD
Morphine—Bradycardia—Prednisone—Crohn's disease	0.00113	0.00197	CcSEcCtD
Morphine—Diarrhoea—Azathioprine—Crohn's disease	0.00112	0.00196	CcSEcCtD
Morphine—Hallucination—Prednisone—Crohn's disease	0.0011	0.00193	CcSEcCtD
Morphine—Hypersensitivity—Mesalazine—Crohn's disease	0.0011	0.00192	CcSEcCtD
Morphine—Connective tissue disorder—Prednisone—Crohn's disease	0.00109	0.00191	CcSEcCtD
Morphine—Dizziness—Azathioprine—Crohn's disease	0.00108	0.00189	CcSEcCtD
Morphine—Asthenia—Mesalazine—Crohn's disease	0.00107	0.00187	CcSEcCtD
Morphine—ABCB1—lymphoid tissue—Crohn's disease	0.00106	0.00963	CbGeAlD
Morphine—Pruritus—Mesalazine—Crohn's disease	0.00105	0.00184	CcSEcCtD
Morphine—ABCB1—digestive system—Crohn's disease	0.00105	0.00951	CbGeAlD
Morphine—Vomiting—Azathioprine—Crohn's disease	0.00104	0.00182	CcSEcCtD
Morphine—Eye disorder—Prednisone—Crohn's disease	0.00104	0.00181	CcSEcCtD
Morphine—Rash—Azathioprine—Crohn's disease	0.00103	0.0018	CcSEcCtD
Morphine—Dermatitis—Azathioprine—Crohn's disease	0.00103	0.0018	CcSEcCtD
Morphine—Flushing—Prednisone—Crohn's disease	0.00103	0.0018	CcSEcCtD
Morphine—Headache—Azathioprine—Crohn's disease	0.00102	0.00179	CcSEcCtD
Morphine—Diarrhoea—Mesalazine—Crohn's disease	0.00102	0.00178	CcSEcCtD
Morphine—Angiopathy—Prednisone—Crohn's disease	0.00101	0.00176	CcSEcCtD
Morphine—Dizziness—Mesalazine—Crohn's disease	0.000984	0.00172	CcSEcCtD
Morphine—Mental disorder—Prednisone—Crohn's disease	0.000971	0.0017	CcSEcCtD
Morphine—Nausea—Azathioprine—Crohn's disease	0.000971	0.0017	CcSEcCtD
Morphine—Erythema—Prednisone—Crohn's disease	0.000965	0.00169	CcSEcCtD
Morphine—Malnutrition—Prednisone—Crohn's disease	0.000965	0.00169	CcSEcCtD
Morphine—Vomiting—Mesalazine—Crohn's disease	0.000946	0.00166	CcSEcCtD
Morphine—Rash—Mesalazine—Crohn's disease	0.000939	0.00164	CcSEcCtD
Morphine—Dermatitis—Mesalazine—Crohn's disease	0.000938	0.00164	CcSEcCtD
Morphine—Headache—Mesalazine—Crohn's disease	0.000933	0.00163	CcSEcCtD
Morphine—Vision blurred—Prednisone—Crohn's disease	0.000909	0.00159	CcSEcCtD
Morphine—Ill-defined disorder—Prednisone—Crohn's disease	0.000895	0.00157	CcSEcCtD
Morphine—Anaemia—Prednisone—Crohn's disease	0.000892	0.00156	CcSEcCtD
Morphine—Agitation—Prednisone—Crohn's disease	0.000887	0.00155	CcSEcCtD
Morphine—Nausea—Mesalazine—Crohn's disease	0.000884	0.00155	CcSEcCtD
Morphine—Malaise—Prednisone—Crohn's disease	0.00087	0.00152	CcSEcCtD
Morphine—Vertigo—Prednisone—Crohn's disease	0.000867	0.00152	CcSEcCtD
Morphine—Syncope—Prednisone—Crohn's disease	0.000865	0.00151	CcSEcCtD
Morphine—Loss of consciousness—Prednisone—Crohn's disease	0.000848	0.00148	CcSEcCtD
Morphine—Convulsion—Prednisone—Crohn's disease	0.000836	0.00146	CcSEcCtD
Morphine—Hypertension—Prednisone—Crohn's disease	0.000833	0.00146	CcSEcCtD
Morphine—Arthralgia—Prednisone—Crohn's disease	0.000822	0.00144	CcSEcCtD
Morphine—Anxiety—Prednisone—Crohn's disease	0.000819	0.00143	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000816	0.00143	CcSEcCtD
Morphine—Discomfort—Prednisone—Crohn's disease	0.000812	0.00142	CcSEcCtD
Morphine—Anaphylactic shock—Prednisone—Crohn's disease	0.000788	0.00138	CcSEcCtD
Morphine—Oedema—Prednisone—Crohn's disease	0.000788	0.00138	CcSEcCtD
Morphine—Infection—Prednisone—Crohn's disease	0.000782	0.00137	CcSEcCtD
Morphine—Shock—Prednisone—Crohn's disease	0.000775	0.00136	CcSEcCtD
Morphine—Nervous system disorder—Prednisone—Crohn's disease	0.000772	0.00135	CcSEcCtD
Morphine—Tachycardia—Prednisone—Crohn's disease	0.000769	0.00134	CcSEcCtD
Morphine—Skin disorder—Prednisone—Crohn's disease	0.000765	0.00134	CcSEcCtD
Morphine—Hyperhidrosis—Prednisone—Crohn's disease	0.000761	0.00133	CcSEcCtD
Morphine—Anorexia—Prednisone—Crohn's disease	0.000751	0.00131	CcSEcCtD
Morphine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000718	0.00126	CcSEcCtD
Morphine—Insomnia—Prednisone—Crohn's disease	0.000712	0.00125	CcSEcCtD
Morphine—Paraesthesia—Prednisone—Crohn's disease	0.000707	0.00124	CcSEcCtD
Morphine—Dyspepsia—Prednisone—Crohn's disease	0.000693	0.00121	CcSEcCtD
Morphine—Decreased appetite—Prednisone—Crohn's disease	0.000685	0.0012	CcSEcCtD
Morphine—Fatigue—Prednisone—Crohn's disease	0.000679	0.00119	CcSEcCtD
Morphine—Constipation—Prednisone—Crohn's disease	0.000673	0.00118	CcSEcCtD
Morphine—Feeling abnormal—Prednisone—Crohn's disease	0.000649	0.00114	CcSEcCtD
Morphine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000644	0.00113	CcSEcCtD
Morphine—Urticaria—Prednisone—Crohn's disease	0.000626	0.00109	CcSEcCtD
Morphine—Abdominal pain—Prednisone—Crohn's disease	0.000623	0.00109	CcSEcCtD
Morphine—Body temperature increased—Prednisone—Crohn's disease	0.000623	0.00109	CcSEcCtD
Morphine—ABCB1—lymph node—Crohn's disease	0.0006	0.00543	CbGeAlD
Morphine—Hypersensitivity—Prednisone—Crohn's disease	0.00058	0.00101	CcSEcCtD
Morphine—Asthenia—Prednisone—Crohn's disease	0.000565	0.000988	CcSEcCtD
Morphine—Pruritus—Prednisone—Crohn's disease	0.000557	0.000975	CcSEcCtD
Morphine—Diarrhoea—Prednisone—Crohn's disease	0.000539	0.000943	CcSEcCtD
Morphine—Dizziness—Prednisone—Crohn's disease	0.000521	0.000911	CcSEcCtD
Morphine—OPRM1—Signaling by GPCR—ACKR2—Crohn's disease	0.000508	0.00169	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000507	0.00169	CbGpPWpGaD
Morphine—Vomiting—Prednisone—Crohn's disease	0.000501	0.000876	CcSEcCtD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000498	0.00166	CbGpPWpGaD
Morphine—Rash—Prednisone—Crohn's disease	0.000497	0.000869	CcSEcCtD
Morphine—Dermatitis—Prednisone—Crohn's disease	0.000496	0.000868	CcSEcCtD
Morphine—OPRD1—GPCR downstream signaling—CCR9—Crohn's disease	0.000496	0.00165	CbGpPWpGaD
Morphine—Headache—Prednisone—Crohn's disease	0.000493	0.000863	CcSEcCtD
Morphine—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.000492	0.00164	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—MLN—Crohn's disease	0.000481	0.0016	CbGpPWpGaD
Morphine—OPRM1—TCR Signaling Pathway—IL1B—Crohn's disease	0.000474	0.00158	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—IL10—Crohn's disease	0.00047	0.00157	CbGpPWpGaD
Morphine—Nausea—Prednisone—Crohn's disease	0.000468	0.000818	CcSEcCtD
Morphine—OPRL1—Circadian rythm related genes—IL6—Crohn's disease	0.000461	0.00154	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—GPR65—Crohn's disease	0.000461	0.00154	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PLA2G4F—Crohn's disease	0.00046	0.00153	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CCR9—Crohn's disease	0.00045	0.0015	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—PTGER4—Crohn's disease	0.000449	0.00149	CbGpPWpGaD
Morphine—CYP2C8—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000439	0.00146	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—CXCL8—Crohn's disease	0.000439	0.00146	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CCR9—Crohn's disease	0.000435	0.00145	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CCR6—Crohn's disease	0.000431	0.00143	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	0.000419	0.0014	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—GPR65—Crohn's disease	0.000418	0.00139	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CCR6—Crohn's disease	0.000413	0.00137	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ACKR2—Crohn's disease	0.000405	0.00135	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—GPR65—Crohn's disease	0.000404	0.00135	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000404	0.00135	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CCR9—Crohn's disease	0.000395	0.00131	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—MTMR3—Crohn's disease	0.000391	0.0013	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PLA2G4F—Crohn's disease	0.000391	0.0013	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MLN—Crohn's disease	0.000384	0.00128	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.000379	0.00126	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000376	0.00125	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—RBX1—Crohn's disease	0.000373	0.00124	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.000367	0.00122	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—GPR65—Crohn's disease	0.000367	0.00122	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—IL2RA—Crohn's disease	0.000367	0.00122	CbGpPWpGaD
Morphine—OPRD1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000367	0.00122	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PTGER4—Crohn's disease	0.000363	0.00121	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ACKR2—Crohn's disease	0.000355	0.00118	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TAGAP—Crohn's disease	0.000351	0.00117	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.000342	0.00114	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MLN—Crohn's disease	0.000336	0.00112	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CCR9—Crohn's disease	0.000334	0.00111	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—MTMR3—Crohn's disease	0.000333	0.00111	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CCR6—Crohn's disease	0.000328	0.00109	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—UBE2D1—Crohn's disease	0.000327	0.00109	CbGpPWpGaD
Morphine—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000322	0.00107	CbGpPWpGaD
Morphine—OPRK1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000321	0.00107	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00032	0.00107	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PLA2G4F—Crohn's disease	0.000318	0.00106	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—RIPK2—Crohn's disease	0.000317	0.00106	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—GPR65—Crohn's disease	0.00031	0.00103	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—IL3—Crohn's disease	0.000309	0.00103	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000309	0.00103	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TAGAP—Crohn's disease	0.000308	0.00102	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—RSPO3—Crohn's disease	0.000307	0.00102	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—FADS1—Crohn's disease	0.000305	0.00102	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ACKR2—Crohn's disease	0.0003	0.000999	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—RASGRP1—Crohn's disease	0.000299	0.000997	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CCR6—Crohn's disease	0.000298	0.000993	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000295	0.000984	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SEL1L—Crohn's disease	0.000291	0.000969	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000289	0.000963	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CCR6—Crohn's disease	0.000288	0.000959	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GPX4—Crohn's disease	0.000285	0.000951	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MLN—Crohn's disease	0.000284	0.000947	CbGpPWpGaD
Morphine—OPRM1—TCR Signaling Pathway—IL6—Crohn's disease	0.000277	0.000924	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—IFNG—Crohn's disease	0.000277	0.000921	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—GCKR—Crohn's disease	0.000276	0.000919	CbGpPWpGaD
Morphine—OPRM1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000272	0.000905	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—JAK2—Crohn's disease	0.000272	0.000905	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000271	0.000903	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—SOCS1—Crohn's disease	0.000271	0.000903	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—MTMR3—Crohn's disease	0.00027	0.000901	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RSPO3—Crohn's disease	0.000269	0.000896	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCR9—Crohn's disease	0.000266	0.000886	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000265	0.000882	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000265	0.000882	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PTGER4—Crohn's disease	0.000263	0.000875	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CCR6—Crohn's disease	0.000261	0.000871	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TAGAP—Crohn's disease	0.00026	0.000866	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—FADS1—Crohn's disease	0.000259	0.000864	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—TYK2—Crohn's disease	0.000259	0.000861	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	0.000257	0.000857	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SEL1L—Crohn's disease	0.000255	0.000849	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000253	0.000844	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000249	0.00083	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000248	0.000826	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—GPR65—Crohn's disease	0.000247	0.000824	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—IL1B—Crohn's disease	0.000247	0.000822	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—JAK2—Crohn's disease	0.000247	0.000822	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—IL3—Crohn's disease	0.000246	0.00082	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000246	0.000819	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.000243	0.000811	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GPX4—Crohn's disease	0.000243	0.000809	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000238	0.000793	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GCKR—Crohn's disease	0.000234	0.000781	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—SMAD3—Crohn's disease	0.000234	0.00078	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000233	0.000777	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCR9—Crohn's disease	0.000233	0.000777	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PTGER4—Crohn's disease	0.00023	0.000767	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000229	0.000763	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RSPO3—Crohn's disease	0.000227	0.000757	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—CXCL8—Crohn's disease	0.000225	0.00075	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL3—Crohn's disease	0.000224	0.000745	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000221	0.000736	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—IL2RA—Crohn's disease	0.000217	0.000722	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—GPR65—Crohn's disease	0.000217	0.000722	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000216	0.00072	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—IL3—Crohn's disease	0.000216	0.000719	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000216	0.000718	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SEL1L—Crohn's disease	0.000215	0.000718	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000214	0.000714	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—FADS1—Crohn's disease	0.000211	0.000702	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000209	0.000696	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GPX4—Crohn's disease	0.000197	0.000657	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCR9—Crohn's disease	0.000197	0.000656	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL3—Crohn's disease	0.000196	0.000653	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.000195	0.000648	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GCKR—Crohn's disease	0.000191	0.000635	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—RASGRP1—Crohn's disease	0.00019	0.000632	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—ALB—Crohn's disease	0.000187	0.000624	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—CXCL8—Crohn's disease	0.000187	0.000624	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000187	0.000622	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—GPR65—Crohn's disease	0.000183	0.00061	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—IL3—Crohn's disease	0.000182	0.000608	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000182	0.000607	CbGpPWpGaD
Morphine—ABCB1—Allograft Rejection—TNF—Crohn's disease	0.000179	0.000596	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000176	0.000588	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCR6—Crohn's disease	0.000176	0.000587	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000172	0.000575	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	0.000167	0.000558	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL3—Crohn's disease	0.000166	0.000552	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000165	0.000549	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—CXCL8—Crohn's disease	0.000164	0.000547	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PTGS2—Crohn's disease	0.000164	0.000546	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—ALB—Crohn's disease	0.000164	0.000546	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—ALB—Crohn's disease	0.000164	0.000546	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.00016	0.000534	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—RBX1—Crohn's disease	0.000159	0.000531	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL2RA—Crohn's disease	0.000157	0.000522	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTGER4—Crohn's disease	0.000155	0.000517	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCR6—Crohn's disease	0.000154	0.000515	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TYK2—Crohn's disease	0.000153	0.000509	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000151	0.000504	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PLA2G4F—Crohn's disease	0.000146	0.000486	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—JAK2—Crohn's disease	0.000146	0.000485	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PTGS2—Crohn's disease	0.000143	0.000477	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PTGS2—Crohn's disease	0.000143	0.000477	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—MTMR3—Crohn's disease	0.000142	0.000474	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RBX1—Crohn's disease	0.00014	0.000465	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—UBE2D1—Crohn's disease	0.00014	0.000465	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.000139	0.000462	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	0.000137	0.000458	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL2RA—Crohn's disease	0.000137	0.000458	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTGER4—Crohn's disease	0.000136	0.000453	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—RIPK2—Crohn's disease	0.000135	0.000451	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CXCL8—Crohn's disease	0.000133	0.000443	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL3—Crohn's disease	0.000132	0.00044	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000131	0.000436	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCR6—Crohn's disease	0.000131	0.000435	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000128	0.000426	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—RASGRP1—Crohn's disease	0.000128	0.000426	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—IL6—Crohn's disease	0.000126	0.000421	CbGpPWpGaD
Morphine—ABCB1—Metabolism—MTMR3—Crohn's disease	0.000124	0.000413	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—UBE2D1—Crohn's disease	0.000122	0.000408	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RIPK2—Crohn's disease	0.000119	0.000396	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RBX1—Crohn's disease	0.000118	0.000393	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—MTMR3—Crohn's disease	0.000117	0.000389	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.000116	0.000387	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—JAK2—Crohn's disease	0.000116	0.000386	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL3—Crohn's disease	0.000116	0.000386	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SOCS1—Crohn's disease	0.000116	0.000386	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTGER4—Crohn's disease	0.000115	0.000383	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RASGRP1—Crohn's disease	0.000112	0.000373	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—FADS1—Crohn's disease	0.000111	0.00037	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—TYK2—Crohn's disease	0.00011	0.000368	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—STAT3—Crohn's disease	0.000107	0.000356	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000106	0.000352	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—JAK2—Crohn's disease	0.000105	0.000351	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GPX4—Crohn's disease	0.000104	0.000346	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.000104	0.000345	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—JAK2—Crohn's disease	0.000102	0.000339	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SOCS1—Crohn's disease	0.000101	0.000338	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RIPK2—Crohn's disease	0.0001	0.000334	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GCKR—Crohn's disease	0.0001	0.000334	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SMAD3—Crohn's disease	9.99e-05	0.000333	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL3—Crohn's disease	9.79e-05	0.000326	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—TYK2—Crohn's disease	9.68e-05	0.000322	CbGpPWpGaD
Morphine—ABCB1—Metabolism—FADS1—Crohn's disease	9.66e-05	0.000322	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CXCL8—Crohn's disease	9.61e-05	0.00032	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RASGRP1—Crohn's disease	9.47e-05	0.000315	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CXCL8—Crohn's disease	9.28e-05	0.000309	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL2RA—Crohn's disease	9.25e-05	0.000308	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—JAK2—Crohn's disease	9.23e-05	0.000308	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—FADS1—Crohn's disease	9.11e-05	0.000303	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GPX4—Crohn's disease	9.05e-05	0.000301	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	8.99e-05	0.000299	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	8.83e-05	0.000294	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—ALB—Crohn's disease	8.78e-05	0.000292	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SMAD3—Crohn's disease	8.76e-05	0.000292	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GCKR—Crohn's disease	8.74e-05	0.000291	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—JAK2—Crohn's disease	8.59e-05	0.000286	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SOCS1—Crohn's disease	8.58e-05	0.000286	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GPX4—Crohn's disease	8.53e-05	0.000284	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CXCL8—Crohn's disease	8.43e-05	0.000281	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GCKR—Crohn's disease	8.24e-05	0.000274	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—TYK2—Crohn's disease	8.18e-05	0.000272	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL2RA—Crohn's disease	8.11e-05	0.00027	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CXCL8—Crohn's disease	7.84e-05	0.000261	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—JAK2—Crohn's disease	7.8e-05	0.00026	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTGS2—Crohn's disease	7.68e-05	0.000256	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—MTMR3—Crohn's disease	7.64e-05	0.000255	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—IL6—Crohn's disease	7.47e-05	0.000249	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—ALB—Crohn's disease	7.46e-05	0.000249	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SMAD3—Crohn's disease	7.41e-05	0.000247	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	7.17e-05	0.000239	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CXCL8—Crohn's disease	7.12e-05	0.000237	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL2RA—Crohn's disease	6.86e-05	0.000228	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTGS2—Crohn's disease	6.53e-05	0.000217	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TYK2—Crohn's disease	6.52e-05	0.000217	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	6.27e-05	0.000209	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—JAK2—Crohn's disease	6.22e-05	0.000207	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ALB—Crohn's disease	6.06e-05	0.000202	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—FADS1—Crohn's disease	5.95e-05	0.000198	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	5.94e-05	0.000198	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TYK2—Crohn's disease	5.72e-05	0.00019	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCL8—Crohn's disease	5.68e-05	0.000189	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GPX4—Crohn's disease	5.58e-05	0.000186	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—JAK2—Crohn's disease	5.45e-05	0.000182	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL6—Crohn's disease	5.4e-05	0.00018	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GCKR—Crohn's disease	5.38e-05	0.000179	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTGS2—Crohn's disease	5.3e-05	0.000177	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCL8—Crohn's disease	4.98e-05	0.000166	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TYK2—Crohn's disease	4.83e-05	0.000161	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL6—Crohn's disease	4.73e-05	0.000158	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—JAK2—Crohn's disease	4.61e-05	0.000154	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—STAT3—Crohn's disease	4.56e-05	0.000152	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCL8—Crohn's disease	4.21e-05	0.00014	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—STAT3—Crohn's disease	4e-05	0.000133	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL6—Crohn's disease	4e-05	0.000133	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—STAT3—Crohn's disease	3.38e-05	0.000113	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ALB—Crohn's disease	3.19e-05	0.000106	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL6—Crohn's disease	3.19e-05	0.000106	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL6—Crohn's disease	2.8e-05	9.31e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS2—Crohn's disease	2.79e-05	9.3e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ALB—Crohn's disease	2.78e-05	9.27e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ALB—Crohn's disease	2.62e-05	8.73e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS2—Crohn's disease	2.43e-05	8.11e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL6—Crohn's disease	2.36e-05	7.87e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.29e-05	7.64e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ALB—Crohn's disease	1.71e-05	5.71e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.5e-05	4.99e-05	CbGpPWpGaD
